Cargando…
BRCA1/ATF1-Mediated Transactivation is Involved in Resistance to PARP Inhibitors and Cisplatin
Homologous recombination (HR)-deficient cells are sensitive to PARP inhibitors through a synthetic lethal effect. We previously developed an HR activity assay named Assay of Site-Specific HR Activity (ASHRA). Here, we evaluated the HR activity of 30 missense variants of BRCA1 by ASHRA and found that...
Autores principales: | Endo, Shino, Yoshino, Yuki, Shirota, Matsuyuki, Watanabe, Gou, Chiba, Natsuko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Association for Cancer Research
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9973406/ https://www.ncbi.nlm.nih.gov/pubmed/36860287 http://dx.doi.org/10.1158/2767-9764.CRC-21-0064 |
Ejemplares similares
-
Evaluation of site-specific homologous recombination activity of BRCA1 by direct quantitation of gene editing efficiency
por: Yoshino, Yuki, et al.
Publicado: (2019) -
The Function of BARD1 in Centrosome Regulation in Cooperation with BRCA1/OLA1/RACK1
por: Otsuka, Kei, et al.
Publicado: (2020) -
Dysregulation of the centrosome induced by BRCA1 deficiency contributes to tissue‐specific carcinogenesis
por: Yoshino, Yuki, et al.
Publicado: (2021) -
Transactivation of the estrogen receptor promoter by BRCA1
por: Archey, William B., et al.
Publicado: (2017) -
BRCA1 transports the DNA damage signal for CDDP‐induced centrosome amplification through the centrosomal Aurora A
por: Qi, Huicheng, et al.
Publicado: (2022)